Columbia Care Inc. (CCHWF)
Columbia Care Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $0.94, down 21.71% on the session, giving a market capitalisation of $521.3M. On trailing twelve-month figures it carries a trailing P/E of -1.16, a net margin of -81.3%. Its beta of 1.76 implies it has historically moved more than the broad market.
Columbia Care Inc. specializes in the cultivation, production, and provision of cannabis merchandise and associated offerings. Its extensive array of products—including flowers, edibles, oils, and tablets—is distributed through recognized brands such as Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD. The enterprise possesses operating permits across 18 distinct regions spanning the United States and the European Union. By June 15, 2022, the company maintained an operational footprint of 131 locations, consisting of 99 retail dispensaries and 32 dedicated cultivation and manufacturing sites. Founded in 2012, Columbia Care Inc.'s corporate headquarters are located in New York, New York.
Columbia Care Inc. is most often compared with the following Healthcare names: